Advanced Malignant Solid Tumors Completed Phase 1 / 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0036787 (Advanced Malignant Solid Tumors)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00445458A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast CancerTreatment